Furthermore, extracellular vesicles from B cells through CD39 and CD73 vesicle-incorporated proteins hydrolyze eATP from chemotherapy-treated tumor cells into adenosine, thus impairing CD8+ T cell responses (131). Here, ENTPD1 is linked to neoplasm.